Oct 19, 2023, 08:45
The 24th of October 2023 is the last day of trading in warrants of series TO 2, which were issued in connection with Carbiotix AB's ("Carbiotix" or the "Company") preferential rights issue of units that was carried out in the spring of 2023. The exercise period runs until the 26th of October 2023.
In connection with the Company's preferential rights issue of units carried out in 2023, 3,190,188 warrants of series TO 2 were issued. Holders of TO 2 have the right to subscribe for one (1) new share in Carbiotix at a price of SEK 1.50 per share during the exercise period, which runs from October 12, 2023, and runs through October 26, 2023.
In order for warrants not to expire without value, the holder is required to subscribe for new shares, by exercising warrants, no later than 17:00 on the 26th of October 2023, or sell warrants no later than on the 24th of October 2023.
An information brochure about the Company and the offer is available on the respective websites of Carbiotix (www.carbiotix.com), Sedermera Corporate Finance AB (www.sedermera.se) and Nordic Issuing AB (www.nordic-issuing.se). Complete terms and instructions for warrants of series TO 2 are available on the Company's website.
In connection with the warrant exercise, Carbiotix has engaged Sedermera Corporate Finance AB as financial advisor, Markets & Corporate Law Nordic AB as legal advisor and Nordic Issuing AB as issuing agent.
For more information about the warrants, please contact:
Sedermera Corporate Finance AB
Tel: +46 (0)40 615 14 10
For more information, please contact:
Erik Deaner, VD
Telefon: +46 (0)73-867 30 85
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome health through a portfolio of prebiotic modulators and diagnostic testing services.